Hazel Perineal Healing Foam

Manufacturer
Jiangsu Senwo Medical Technology Co., Ltd.
Effective date
2025-11-07
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:33:04

Label at a glance#

ProductHazel Perineal Healing Foam
Active ingredientWITCH HAZEL
Label structure9 sections

Storage and handling

Other informationm Store at room temperature Single use per wipe

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Witch Hazel 50%

OTC - PURPOSE SECTION

Astringent

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children lfswallowed,get medica help or contact aPoison Control Center right away.

INDICATIONS & USAGE SECTION

Helps relieve pain and swelling from hemorrhoids and childbirth.

WARNINGS SECTION

For external use only

DOSAGE & ADMINISTRATION SECTION

When using this product m Avoid contact with eyes.lf contact occurs.rinsethoroughly with water..Do not exceed the recommended daily dosage unlessdirected by a doctor m Do not put this product into the rectum by using fingeror any mechanical device or applicator.

STORAGE AND HANDLING SECTION

Other informationm Store at room temperature Single use per wipe

INACTIVE INGREDIENT SECTION

Water
C12-18 ALKYL GLUCOSIDE
SODIUM LAUROYL SARCOSINATE
SODIUM LAUROYL GLUTAMATE
COCAMIDOPROPYL BETAINE
ERYTHRITOL
BUTYLENE GLYCOL
ALCOHOL
HYDROXYACETOPHENONE
1,2-HEXANEDIOL
PHENOXYETHANOL
TOCOPHEROL
SAURURUS CHINENSIS LEAF/ROOT
EXTRACT
TARAXACUM OFFICINALE
(DANDELION) LEAF EXTRACT
STEPHANIA TETRANDRA EXTRACT
MENTHA HAPLOCALYX OIL
CITRIC ACID
PEG-40 HYDROGENATED CASTOR OIL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabellabel2label2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2166922witch hazel 50 % Topical FoamPSN4
2166922witch hazel 500 MG/ML Topical FoamSCD4
2166922witch hazel 50 % Topical FoamSY4

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128X0049CC0P9label2.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85448-001-01Hazel Perineal Healing Foam100 mL in 1 BOTTLELIQUID1004
85448-001-02Hazel Perineal Healing Foam150 mL in 1 BOTTLELIQUID1504

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85448-00185448-001-01, 85448-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Hazel Perineal Healing FoamWITCH HAZELJiangsu Senwo Medical Technology Co., Ltd.314b75cb-affe-a248-e063-6294a90a47b72025-11-07WarningsExact identifier
ndc (package): 85448-001-01
ndc (package): 85448-001-02
ndc (product): 85448-001
ndc11 (package): 85448000102
ndc11 (package): 85448000101
spl id: 42fe1d61-71f5-ecd3-e063-6294a90ac3ad
spl set id: 314b75cb-affe-a248-e063-6294a90a47b7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.